Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Current Opinion in Anaesthesiology|October 4, 2006
Clinical trials in sepsis: an updateJ Sevransky, C NatansonAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 1992
Systemic hemodynamic abnormalities and vasopressor therapy in sepsis and septic shockZ M Quezado, C NatansonExpert Opinion on Investigational Drugs|November 4, 2000
Anti-inflammatory therapies in sepsis and septic shockB D Freeman, C NatansonISBT Science Series|May 29, 2018
Transfusion of fresh vs. older red blood cells in the context of infectionH Klein, C Natanson, W FlegelTrends in Biotechnology|February 1, 1995
New strategies for combatting sepsis: the magic bullets missed the mark ... but the search continuesZ M Quezado, S M Banks, C NatansonEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 13, 2003
Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsisP Minneci, K Deans, C Natanson, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 7, 2009
The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysisP C Minneci, K J Deans, P Q Eichacker, et al.Vox Sanguinis|March 30, 2010
The relevance of practice misalignments to trials in transfusion medicineK J Deans, P C Minneci, H G Klein, et al.Chest|May 1, 1988
Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shockF P Ognibene, M M Parker, C Natanson, et al.Critical Care Medicine|October 1, 1987
Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosisM M Parker, J H Shelhamer, C Natanson, et al.Pageof 6